Allergan’s (AGN) revenue and adjusted EPS figures for Q2 beat market estimates, sending shares up by about 0.7% in premarket trade. The pharma company reported a 2.9% improvement in revenues … Continue reading Allergan posts upbeat results on higher Botox, Juvederm sales